New York’s enforcement gets more teeth 🦷

“We’re going to take another pass at this,” Pennsylvania Republican Sen. Dan Laughlin said, after his bipartisan bill to create a Pennsylvania Cannabis Control Board to oversee the state’s medical industry was voted down in the state Senate. 

“I’m not sure exactly when, but hopefully before the end of June, and hopefully some negotiations will go on between myself and governor’s office to try to get this bill to his desk to protect children in the commonwealth.”

Despite Laughlin’s efforts and Gov. Josh Shapiro’s pro-cannabis rhetoric, recreational cannabis is not yet legal in the Keystone State. 

New York | Courts green-light warrantless inspections of cannabis retailers ⚖️

New York's Third Department Appellate Division ruled that state and city officials can conduct warrantless administrative inspections of cannabis and hemp retailers, reversing a lower court injunction that had blocked them. Regulators argued — and the court agreed — that the Cannabis Law's licensing framework already provides enough constraints to satisfy the Fourth Amendment.

NORML case could be the key to blocking cannabis rescheduling ⚖️

Plaintiffs in the rescheduling lawsuit argue a prior NORML case requires the government to hold a formal rulemaking hearing and get HHS sign-off before moving a substance on the CSA, steps they say were skipped here. Attorney Michelle Bodian posted the filing on LinkedIn. The government has until July 2 to respond.

AZUCA*
Your gummies are only as good as what’s inside them

In a crowded edibles market, formulation is becoming a competitive moat. 

Consumers who try a fast-acting product and get the experience they expected — onset in 5 to 15 minutes, consistent every time — come back. 

Those who don't, don't.

Azuca has spent eight years solving this problem for brands in regulated markets. Their TiME INFUSION® process — Thermodynamic individual Molecular Encapsulation® — encapsulates individual cannabinoid molecules to make them water-friendly, bioavailable, and reliably fast-acting. The result is a formulation that performs predictably across batches, SKUs, and state lines.

The company has now delivered more than 700 million precisely dosed servings globally, including in medical and adult-use markets across the U.S., Canada, and Australia. They've been recognized twice on the Inc. 5000 and named to Forbes' Cannabis 42.0 list.

Whether you're developing new products or looking to upgrade an existing line, Azuca is worth a conversation. → azuca.co

*sponsored

Maine recalls cannabis flower over mold concerns 🌿

Maine's Office of Cannabis Policy issued a recall for "Drip Burger," a strain from producer Green Trap sold at seven retail stores, after audit testing found unsafe levels of yeast and mold. The affected batches were sold between April 29 and June 8 in eighth- and half-ounce quantities.

Tilray Brands launched ARX, a new premium medical cannabis brand grown at its Neumünster facility in Germany. $TLRY ( ▲ 1.99% )

Thomas Winstanley was promoted to president of Edibles.com. Winstanley is a friend of Cultivated and has been on our show numerous times. 

Village Farms named Kip Woodward as board chairman, succeeding John McLernon who held the role for 20 years. $VFF ( 0.0% )

Frank Colombo joined Sharpe Credit Partners as Chief Credit Officer, overseeing the firm's Sweet Leaf Finance cannabis lending affiliate.

Zac Efron is building a hemp-based home near Byron Bay, Australia, dubbed "FutureCave," using the plant for everything from bricks to bedding.